Our results are further supported by the previously proposed mechanism involving Toll-like receptor 4 (TLR4), overexpressed in breast cancer patients with lymph node metastasis, that was induced in both ET-treated human breast cancer cells, MCF-7 and MDA-MB-231, resulting in increased invasiveness [43]. This evidence concerns the gene TLR4 and breast cancer.